In a world first, youngest child undergoes own cord blood reinfusion to determine potential to prevent or delay onset of Type 1 Diabetes

In a world first, youngest child undergoes own cord blood reinfusion to determine potential to prevent or delay onset of Type 1 Diabetes

As part of The CORD study (Cord Reinfusion in Diabetes), Lucy, a 20 month old Australian girl, was reinfused with her own umbilical cord blood to determine whether it will delay or prevent the onset of type 1 diabetes. The study is being conducted through the Kids...
Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Canadian Company Initiates Clinical Trial Using an Expanded Cord Blood for Acute Myeloid Leukemia (AML)

Research Update- AML Trial ExCellThera is a clinical stage biotech company that is focused on developing a robust and cost effective technology to expand blood stem cells from cord blood for therapeutic use. ExCellThera is a spin-off company from the Institute for...
add chat to your website

Get Info Pack

Take the first step to learn about cord blood and cord tissue banking today!

$250 OFF Cord Blood & Tissue Storage or 
$150 OFF 
Cord Blood Storage Only
 

Use Promo Code:

NY250 for $250 off Cord Blood & Tissue OR
NY150 for $150 off Cord Blood Storage only
ENROLL NOW
Terms & Conditions: apply. Limited time offer. This offer cannot be used in conjunction with any other Insception Lifebank offers and is not redeemable for cash . 
close-link
Questions about cord blood and COVID-19? 
Read company statement here >>
close-image
Blog Clinical Trials